Eisler Capital (UK)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$586K Sell
11,317
-23,602
-68% -$1.11M ﹤0.01% 522
2024
Q2
$1.45M Buy
34,919
+25,898
+287% +$1.16M 0.01% 422
2024
Q1
$489K Sell
9,021
-2,932
-25% -$149K ﹤0.01% 556
2023
Q4
$613K Buy
+11,953
New +$627K ﹤0.01% 549

Other funds holding BMY

Eisler Capital (UK)'s BMY Position: Q3 2024 in Review

Eisler Capital (UK) reduced its Bristol-Myers Squibb (BMY) stake by 68% in Q3 2024, selling an estimated $1.11M and leaving 11,317 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

Eisler Capital (UK) first reported a position in BMY in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.45M in Q2 2024. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Eisler Capital (UK) held 11,317 shares of Bristol-Myers Squibb worth $586K as of Q3 2024.
  • Eisler Capital (UK) sold 23,602 Bristol-Myers Squibb shares in Q3 2024, an estimated $1.11M.
  • Bristol-Myers Squibb made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #522 holding.
  • Eisler Capital (UK) first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 4 quarters since.
  • Eisler Capital (UK)'s Bristol-Myers Squibb position peaked at $1.45M in Q2 2024.
  • 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.